Product Theater: Novo Nordisk - The CV Game Plan: Exploring GLP-1 RA options for Appropriate Patients With T2D
Tuesday, December 8, 2026, – (America/New_York)
Product Theater
Participants will engage in an interactive gaming experience that integrates key educational content throughout gameplay, centered on GLP-1 RAs. Players will explore findings from two cardiovascular outcomes trials and explore the role of GLP-1 RA options to help manage cardiovascular risk in appropriate patients with type 2 diabetes. Dosing and administration are incorporated in the experience, with core information embedded within the game to support understanding in an engaging format.
Speakers
-
MSN, APN-BC,BC-ADM, Division of Endocrinology, Diabetes, Bone Disorders Henry Ford Health System